ATRX and soft tissue sarcoma: To study the role of ATRX in cancer development and therapeutic response, we generated a primary genetically engineered mouse model of soft tissue sarcoma with or without Atrx deletion in tumor cells with deletion of both alleles of Trp53 and activation of oncogenic KrasG12D.